Richcore Lifesciences Pvt. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Richcore Lifesciences Pvt. Ltd. - overview
Location
Bangalore, Karnataka, India
Primary Industry
Biotechnology
About
Based in Bangalore, India, Richcore Lifesciences Pvt. Ltd. is a biotechnology company that researches and develops novel solutions for "non-animal origin" proteins for the fields of stem cell and regenerative medicine, vaccines and biological drugs, cultured meat, and bio-manufacturing.
Current Investors
Ventureast, Eight Roads Ventures
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Pharmaceutical Research & Development
Website
www.richcoreindia.com
Total Amount Raised
Subscriber access only
Richcore Lifesciences Pvt. Ltd. - financials
| Fiscal Year Ended | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 93,172,524 | 58,929,253 | 80,008,229 | 229,507,013 | 220,011,565 | 217,289,117 | 224,650,868 | 409,577,553 | 510,307,472 | 1,002,762,842 | - | - | - |
| % Revenue Growth (YoY) | - | (36.8%) | 35.8% | 186.9% | (4.1%) | (1.2%) | 3.4% | 82.3% | 24.6% | 96.5% | - | - | - |
| EBITDA (USD) | (55,330,184) | (47,722,973) | (90,285,378) | (16,011,394) | (20,491,493) | 2,581,711 | (14,395,823) | (15,654,912) | 144,126,932 | 331,494,179 | - | - | - |
| Operating Income (USD) | (73,281,115) | (63,853,898) | (121,553,922) | (43,906,443) | (50,077,943) | (31,740,610) | (50,705,401) | (50,223,149) | 113,080,545 | 263,535,498 | - | - | - |
| Operating Margin | (78.7%) | (108.4%) | (151.9%) | (19.1%) | (22.8%) | (14.6%) | (22.6%) | (12.3%) | 22.2% | 26.3% | - | - | - |
| % EBITDA Margin | (59.4%) | (81.0%) | (112.8%) | (7.0%) | (9.3%) | 1.2% | (6.4%) | (3.8%) | 28.2% | 33.1% | - | - | - |
| NET Income (USD) | (69,421,977) | (59,013,640) | (127,803,489) | (53,252,172) | (57,622,472) | (44,807,745) | (70,880,413) | (70,208,828) | 92,771,710 | 201,287,527 | - | - | - |
| % Net Margin | (74.5%) | (100.1%) | (159.7%) | (23.2%) | (26.2%) | (20.6%) | (31.6%) | (17.1%) | 18.2% | 20.1% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.